This is the authors' abstract. We don't add key points for this paper.
Consensus among international experts on response criteria and endpoints in autoimmune hepatitis is lacking. A consensus on endpoints is urgently required to set a global standard for the reporting of study results and to enable the comparison of results between clinical trials. Therefore, the International Autoimmune Hepatitis Group (IAIHG) herein presents a statement on 5 agreed response criteria and endpoints: complete biochemical response, insufficient response, non-response, remission, and intolerance to treatment, which can be used to guide future reporting.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pape et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: